Welcome to Academic Drug Discovery – how to secure that preclinical findings reach the patients
The Medicon Valley universities have many research activities within early drug discovery and they offer a wide range of know-how and research within new therapeutic goals and new and innovative methods to develop drugs. These activities can support drug development not only at the universities but also at other life-science institutions/companies in the region. However, there is currently no clear formalized initiative between academic preclinical drug discovery, clinical trials and the region’s life science industry. How can we ensure maximum exchange between preclinical research findings, related knowledge, and technologies from the academia and the life-science industry and thereby facilitate the progression of novel drug candidates so that they reach all the way to patients and create social benefits?
University of Copenhagen, Lund University, and Medicon Valley Alliance invite you to Academic Drug Discovery – how to secure that preclinical findings reach the patients:
Date: 23 August 2018
Time: 8.30 – 16.30
Venue: Nielsine Nielsen auditorium, The Maersk Tower, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen N
Cost: Free of charge for MVA members
Sign up – This event is fully booked. Please sign up to be included on our waiting list
By strengthening preclinical drug discovery, increasing the number of academic clinical studies, and optimizing trial designs by e.g. including companion diagnostics, important prerequisites to ensure continued growth of the Swedish-Danish life science sector are created. This event intends to serve as a first step in establishing a more effective regional platform for academic/clinical drug research.
Program
08.30-09.00 |
Registration and networking |
09.00-09.15 |
Welcome and introduction |
09.15-09.35 |
NEXT – a public – private partnership to attract clinical trials to Denmark – how do we |
09.35-09.50 |
The patent perspective – Dos and Don’ts |
09.50-10.10 |
The enzyme MTH1 as a novel target in cancer therapy – a journey from the lab bench to first-in-human clinical trial |
10.10-10.30 |
Fish and Grasshoppers in the Service of MANkind |
10.30-11.00 |
Coffee and networking |
11.00-11.20 |
From academic discoverers to biotech |
11.20-11.40 |
Drug discovery in Immuno-Oncology |
11.40-12.00 |
From brain research to applied science – How do we transform great academic ideas into drugs |
12.00-12.20 |
BioInnovation Institute: Helping life science entrepreneurs to bring science out of the |
12.20-13.15 |
Lunch & networking |
13.15-14.45 |
Workshop: How to create a formalized platform for academic drug discovery including infrastructure and know-how |
14.45-15.25 |
Summary of workshop and next step |
15.25-15.45 |
Panel discussion |
15.45-16.30 |
Refreshments and networking |
Deadline for registration is 17th of August, 2018.
For more information please contact Senior Project Manager Helen Pettersson: hp@mva.org
In collaboration